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Background: Riboflavin is required for several redox reactions. Clinical riboflavin deficiency 
occurs mainly in low-income countries, where it is associated with anemia. The functional 
significance of suboptimal riboflavin status in different populations and its role in anemia is 
not well understood. Objectives: We assessed the biomarker status of riboflavin and its 
association with hemoglobin concentration and anemia in women living in Vancouver, Canada, 
and Kuala Lumpur, Malaysia. Methods: Healthy nonpregnant, nonbreastfeeding women (19-
45 y) were recruited from Canada ( n = 206) and Malaysia (n = 210) via convenience sampling. 
Fasting blood was collected to assess riboflavin status [erythrocyte glutathione reductase 
activity coefficient (EGRac)], hematological indicators, soluble transferrin receptor (sTfR), 
ferritin, vitamin A, folate, and vitamin B-12 concentrations. Linear and logistic regression 
models were used to assess the association of riboflavin status with hemoglobin concentration 
and anemia. Results: EGRac (mean ± SD) values were higher, indicating poorer riboflavin 
status, in Malaysian compared with Canadian women (1.49 ± 0.17 compared with 1.38 ± 0.11). 
Likewise, riboflavin biomarker deficiency (EGRac ≥1.40) was significantly more prevalent 
among Malaysians than Canadians (71% compared with 40%). More Malaysian than Canadian 
women were anemic (hemoglobin <120 g/L; 18% compared with 7%). With use of linear 
regression (pooled sample; n = 416), EGRac values were negatively associated with 
hemoglobin concentration (r = -0.18; P < 0.001). This relation remained significant (P = 0.029) 
after adjusting for age, parity, ethnicity, vitamin B-12, folate, sTfR, ferritin, and vitamin A. 
Women with riboflavin deficiency (EGRac ≥1.40) were twice as likely to present with anemia 
(adjusted OR: 2.38; 95% CI: 1.08, 5.27) compared with women with EGRac <1.40. 
Conclusions: Biochemical riboflavin deficiency was observed in Canadian and Malaysian 
women, with higher rates of deficiency among Malaysian women. Deficient biomarker status 
of riboflavin was a weak but significant predictor of hemoglobin and anemia, suggesting that 
the correction of riboflavin deficiency may potentially play a small protective role in anemia, 
but this requires further investigation. 
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